The Analysis of TAKEDA PHARMACEUTICAL CO LTD's Holdings & P&L

Currently, TAKEDA PHARMACEUTICAL CO LTD holds 8 types of securities in its portfolio with a total value $16.4M. In the most recent quarter, they have increased their positions in N/A (+13.7K shares, valued at $222.8K).

1M P&L

+2.8M+9.82%

3M P&L

+13.2M+73.58%

HY P&L

+13.4M+75.71%

P&L figures are estimated based on reported 13F stock holdings and market price changes. They are approximations and may not reflect actual fund performance. Stock split events may also affect the accuracy of these calculations, and we cannot guarantee that all splits have been fully accounted for.

Top Holding Treemap

Top Industries by Value

1Biotechnology15.0M

96.8%

2Health Information Services478.1K

3.1%

3Medical Devices21.5K

0.1%

Top Industries by Stock Count

1Biotechnology5 stocks

71.4%

2Medical Devices1 stocks

14.3%

3Health Information Services1 stocks

14.3%

Sponsored

Stock Holdings

TickerCompany NameSharesShares △%Event DateReport DateHistory

OVID Ovid Therapeutics, Inc.7.5M shares0.00%2025-09-302025-11-13

EQ Equillium, Inc.1.8M shares0.00%2025-09-302025-11-13

XLO Xilio Therapeutics, Inc. (formerly Akrevia Therapeutics)1.5M shares0.00%2025-09-302025-11-13

STTK Shattuck Labs, Inc.515.6K shares0.00%2025-09-302025-11-13

Lyell Immunopharma, Inc. Lyell Immunopharma, Inc.54.9K shares33.33%2025-09-302025-11-13

AMWL American Well Corporation77.7K shares0.00%2025-09-302025-11-13

RANI Rani Therapeutics Holdings, Inc.203.2K shares0.00%2025-09-302025-11-13

LAB Standard Biotools, Inc.16.5K shares0.00%2025-09-302025-11-13